
Pioglitazone Oral Tablets
Form: Oral Tablets
Strength: 15 mg, 30 mg, 45 mg
Reference Brands: Actos (USA, EU), Glustin (EU)
Category: Diabetes
Pioglitazone tablets are FDA-approved in the USA and authorized by the EMA in the EU for the treatment of type 2 diabetes mellitus, either as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas. Marketed under brands such as Actos, Glustin, and their generics, pioglitazone is classified as a thiazolidinedione. It improves glycemic control by enhancing insulin sensitivity in muscle and adipose tissues. Regulatory agencies emphasize cardiovascular risk evaluation and monitor for adverse effects like weight gain and edema. Pharmatradz.com offers regulatory-compliant sourcing and B2B access to pioglitazone from audited manufacturers globally.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Premixed Insulins (70/30, 50/50) Injectable
Strength: U-100
Form: Vials, pens
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
View DetailsInsulin Lispro (Humalog) Injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)
View DetailsInsulin Aspart (Novolog) Injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Novolog, Fiasp(US &EU)
View DetailsInsulin Glargine (Lantus) Injectable
Strength: U-100, U-300
Form: Vials/pens
Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)
View Details